SYK Stock - Stryker Corporation
Unlock GoAI Insights for SYK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $22.59B | $20.50B | $18.45B | $17.11B | $14.35B |
| Gross Profit | $13.98B | $12.49B | $11.04B | $10.71B | $8.75B |
| Gross Margin | 61.9% | 61.0% | 59.8% | 62.6% | 61.0% |
| Operating Income | $5.06B | $4.28B | $3.73B | $3.76B | $3.03B |
| Net Income | $2.99B | $3.17B | $2.36B | $1.99B | $1.60B |
| Net Margin | 13.2% | 15.4% | 12.8% | 11.7% | 11.1% |
| EPS | $7.86 | $8.34 | $6.23 | $5.29 | $4.26 |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Visit WebsiteEarnings History & Surprises
SYKEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Jan 29, 2026 | $4.39 | — | — | — |
Q4 2025 | Oct 30, 2025 | $3.13 | $3.19 | +1.9% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $3.07 | $3.13 | +2.0% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $2.71 | $2.84 | +4.8% | ✓ BEAT |
Q1 2025 | Jan 28, 2025 | $3.87 | $4.01 | +3.6% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $2.77 | $2.87 | +3.6% | ✓ BEAT |
Q3 2024 | Jul 30, 2024 | $2.79 | $2.81 | +0.7% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $2.35 | $2.50 | +6.4% | ✓ BEAT |
Q1 2024 | Jan 30, 2024 | $3.27 | $3.46 | +5.8% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $2.44 | $2.46 | +0.8% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $2.38 | $2.54 | +6.7% | ✓ BEAT |
Q2 2023 | May 1, 2023 | $2.00 | $2.14 | +7.0% | ✓ BEAT |
Q1 2023 | Jan 31, 2023 | $2.84 | $3.00 | +5.6% | ✓ BEAT |
Q4 2022 | Oct 31, 2022 | $2.23 | $2.12 | -4.9% | ✗ MISS |
Q3 2022 | Jul 26, 2022 | $2.27 | $2.25 | -0.9% | ✗ MISS |
Q2 2022 | Apr 28, 2022 | $1.93 | $1.97 | +2.1% | ✓ BEAT |
Q1 2022 | Jan 27, 2022 | $2.72 | $2.71 | -0.4% | ✗ MISS |
Q4 2021 | Oct 28, 2021 | $2.28 | $2.20 | -3.5% | ✗ MISS |
Q3 2021 | Jul 27, 2021 | $2.12 | $2.25 | +6.1% | ✓ BEAT |
Latest News
Frequently Asked Questions about SYK
What is SYK's current stock price?
What is the analyst price target for SYK?
What sector is Stryker Corporation in?
What is SYK's market cap?
Does SYK pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SYK for comparison